Search Options Stock News and Analysis from Schaeffer's

3 Drug Stocks Seeing Unusual Options Trading Today

https://www.schaeffersresearch.com/content/news/2019/05/21/3-drug-stocks-seeing-unusual-options-trading-today

5/21/2019 3:24 PM

U.S. markets are moving higher today, tech recovering from yesterday's sell-off. Three pharmaceutical names also making notable moves this afternoon are Array Biopharma Inc (NASDAQ:ARRY), Sesen Bio...

Analyst: This Biopharma Stock Could Surge 76%

https://www.schaeffersresearch.com/content/options/2019/01/15/analyst-this-biopharma-stock-could-surge-76

1/15/2019 1:42 PM

Cantor Fitzgerald today initiated coverage on Array Biopharma Inc (NASDAQ:ARRY) with an "overweight" rating and $30 price target -- representing a premium of 76% to Monday's close at $17.07. The brok...

3 Drug Stocks Making Outsized Moves Today

https://www.schaeffersresearch.com/content/news/2019/01/07/3-drug-stocks-making-outsized-moves-today

1/7/2019 2:34 PM

Stocks are confidently higher today, powered by fresh U.S-China trade optimism. Drug stocks are in particular focus, as the J.P. Morgan Healthcare conference kicks off. Insmed Incorporated (NASDAQ:IN...

Biotech Stock Flashing "Buy" Signal

https://www.schaeffersresearch.com/content/analysis/2018/10/09/biotech-stock-flashing-buy-signal

10/9/2018 2:26 PM

Last Friday, Array Biopharma Inc (NASDAQ:ARRY) gapped lower for its worst day since July 27, but there is a silver lining. That is, the pullback puts ARRY near a historically bullish trendline and ke...

FDA Nod Could Rattle Array Biopharma Shorts

https://www.schaeffersresearch.com/content/news/2018/08/07/fda-nod-could-rattle-array-biopharma-shorts

8/7/2018 9:17 AM

Boulder-based Array Biopharma Inc (NASDAQ:ARRY) is attracting pre-market attention this morning, after its BRAFTOVI drug, in combination with MEKTOVI and cetuximab, was given a Breakthrough Therapy D...

PEOPLE ALSO SEARCH FOR